Trials Underway Using Experimental CAR T-Cell Therapy For Deadly Childhood Brain Cancer
"Diffuse intrinsic pontine glioma (DIPG) is one of the hardest to treat cancers and most children diagnosed with it die within a year, with standard therapies failing to provide any chance of long-term survival. Now two clinical trials are underway to assess the effectiveness of a type of cell-based therapy called CAR T-cells in tackling the disease and another, related disease with a similarly poor prognosis, called diffuse midline glioma (DMG)."